Search PubMed⌕ Search

Biomedical subjects

F B Aiello

Publications and source records attributed to F B Aiello.

26 records · Page 2Linked to original sources
PubMed1986

Phenotypical characteristics and proliferative capabilities of thymocyte subsets in human thymoma.

The phenotypical and functional characteristics of the lymphoid component present in ten human thymomas have been analyzed. Thymomas were classified according to the predominant epithelial cell type present in the neoplastic gland. In thymomas of the cortical type a large proportion, clearly higher than that present in mixed thymomas, of T6-positive lymphocytes was present. This T6 subset did not proliferate to mitogen but contained almost all thymocytes able to spontaneously proliferate. Higher proportions of T3-positive cells were found in mixed types of thymomas than in cortical-type tumors. This T3+ subset responded to mitogen stimulation and constituted the more mature intrathymic pool. Surprisingly we identified in thymomas a further subset, lacking the cortical and medullary markers T6 and T3, capable of responding to mitogen. The occurrence of higher proliferative responses to phytohemagglutinin (PHA) in the unfractionated population of cells from mixed thymomas than in the cells of cortical thymomas was judged to be attributable to the relatively higher content of both T3-positive and T3, T6-negative thymocytes in the former. Unlike T6+ thymocytes, T3-T6- as well as T3+ cells were practically devoid of spontaneous proliferative capacity. The expansion of the intrathymic lymphoid component in human thymomas should then be considered to be attributable to the "spontaneous" proliferative capacity of the T6+ cell pool. In this respect, cortical thymomas not only contained more T6+ cells than the mixed type but also exhibited a higher lymphocyte/epithelial cell ratio and more frequent mitotic figures.

Cell Separation↗
PubMed1986

The mature, mitogen-responsive, human thymocyte population comprises two functionally distinct T-cell subsets differing in exogenous interleukin requirements for mitogenesis and in sensitivity to glucocorticoids.

Human thymocytes were separated into 10 fractions by continuous Percoll density gradient centrifugation. Almost all the cells able to proliferate in response to phytohaemagglutinin (PHA) and about 80% of the thymocytes carrying the mature T3 marker were contained within the first two lightest fractions (Fr1 and Fr2). However, cells in Fr1 and in Fr2 were clearly different in terms of their interleukin requirement for mitogenesis, i.e. in the presence of interleukin-1 (IL-1), Fr1 thymocytes showed proliferative responses to PHA that were three to five times greater than those of the Fr2 cells, whereas in the presence of exogenous IL-2 both Fr1 and Fr2 cells had mitogenic responses of a similar magnitude. These differences could not be explained by accessory cell contamination or by different kinetics of the proliferative responses. Furthermore, in the presence of exogenous IL-1, Fr1 thymocytes showed a greater capacity for producing IL-2. In contrast, there was no difference in the expression of functional IL-2 receptors between the two fractions. It can be concluded that the mature thymocyte subpopulation contains at least two functionally distinct subsets, which differ in density, and that during intrathymic maturation the capacities to produce and to respond to IL-2 do not develop simultaneously. Although both the number and the binding characteristics of glucocorticoid (GC) receptor sites did not differ significantly between Fr1 and Fr2 thymocytes, dexamethasone was more effective in inhibiting the PHA-induced mitogenesis of Fr2 than of Fr1 cells. Thus, the GC sensitivity of T-cell mitogenesis is not directly correlated with receptor-related variables. In contrast with observations made on peripheral T cells, the inhibitory activity of GC on thymocyte mitogenesis was only partially reversed by the addition of exogenous IL-2. Thus, the inhibitory action of GC on thymocyte mitogenesis cannot be explained only by the steroid-induced inhibition of IL-1--IL-2 production; it must also be due to a GC-inhibitory effect on the IL-2-responsive cell proliferation.

Antigen-Presenting Cells↗
PubMed1986

Estrogen binding sites in peripheral blood mononuclear cells and thymocytes from 2 myasthenia gravis patients.

In the present investigation the estrogen binding capacity of peripheral blood mononuclear cells (PBMC) and thymocytes from 2 young female Myasthenia Gravis (MG) patients has been studied. We found high levels of estrogen binding sites in both pre-thymectomy PBMC and lymphoid cells from the hyperplastic thymuses of the MG patients. A sucrose density gradient analysis revealed that the estrogen was binding to macromolecular species similar to those characterized in cytosols from classical estrogen target organs. A post-thymectomy time-dependent decrease of the estrogen binding capacity was also observed in PBMC, reaching levels similar to that of sex- and age-matched controls.

Adolescent↗
PubMed1985

Proliferative capabilities of T3-positive thymocytes.

The proliferative responses to phytohemagglutinin (PHA) and to OKT3 monoclonal antibody of various human thymocyte subsets were studied. Unfractionated thymocytes are very poorly responsive cells, as assessed by both PHA and OKT3 stimulation. The mitogen responsiveness is confined to the T3-enriched (T3+) subset, the T6-positive (T6+) cells being almost completely devoid of proliferative capacity. The addition of exogenous IL-2 increases the proliferative responses to PHA and OKT3 of both unfractionated and T3+ thymocytes. This implies that the endogenous IL-2 production by thymocytes is inadequate to fully support the intrinsic proliferative capacity of these cells. Even in the presence of an optimal amount of IL-2, T3+ thymocytes exhibit proliferative responses of lower magnitude as compared to those of peripheral T counterpart (PBT). These observations indicate that the maturative level attained by the T3+ subpopulation within the thymus is considerably inferior to that of T3+ fully immunocompetent peripheral T lymphocytes. Macrophages are activated to produce IL-1 following the stimulation by OKT3-pulsed T lymphocytes. T3+ thymocytes are markedly less efficient than PBT in inducing IL-1 secretion. These data suggest that T3+ lymphocytes within the thymus are relatively immature in terms of cooperative capacities with accessory cells. In conclusion, T3+ cells constituting the more mature intrathymic pool do not reach a complete functional differentiation as compared with the T3+ peripheral counterpart.

Antibodies, Monoclonal↗
PubMed1985

T3 expression by human thymocytes in culture.

By panning procedures employing T6 and T3 monoclonal antibody, human thymocytes were fractionated into two subpopulations depleted of T6- or T3-positive (T6+, T3+) cells. Unfractionated thymocytes and T6- and T3-depleted subpopulations were separately cultured for 48 h in RPMI 1640 medium with 10% FCS or in HB 101 serum-free medium. Determining the phenotype of unfractionated thymocytes at various time intervals, a time-dependent increase of T3+ cells was observed. An inverse relationship was found between the percentage of T3+ cells and the T6 and peanut agglutinin (PNA) reactive thymocytes. When the surface antigen expression in the T3-depleted population (greater than 95% T6+ and PNA+ cells) was analysed, a strong increase of T3+ cells and a complementary reduction of T6+ and PNA+ cells was evidenced. During that time the surface phenotype of the T6-depleted population (greater than 80% T3+ cells) showed the same trend of differentiation, as the other thymocyte preparations. These results indicate that a conspicuous fraction of human thymocytes and particularly of those characterized by a cortical phenotype (PNA+ and T6+ cells), are able to express mature T-cell antigens when cultured in vitro in the absence of the thymic microenvironment influence. However, the in vitro acquisition of a mature phenotype is not accompanied by a parallel achievement of the capacity to respond to mitogens such as PHA or T3 monoclonal antibody.

Antibodies, Monoclonal↗
PubMed1985

Ultrastructural analysis of peripheral blood mononuclear cells in renal allograft recipients.

Renal transplanted patients receiving immunosuppressive therapy with glucocorticoids (GC) and azathioprine show in the peripheral blood numerous large mononuclear cells. The origin and the lineage of these cells was not clearly established. In the present study we investigated the surface phenotype and the ultrastructural characteristics of this subset constituted by large mononuclear cells. From peripheral blood mononuclear cells (PBL) of allograft recipients, a cell preparation exhaustively depleted of the relatively numerous monocytes was obtained. At ultrastructural examination two main cellular populations were distinguished: the predominant one (congruent to 85%) was constituted by cells with lymphoid morphology while the other (congruent to 15%) showed myeloid appearance. The large lymphoid cells, T4 or T8 positive, did not express Ia molecules on the surface and were morphologically suggestive of cells in an intermediate stage of the cell cycle between resting and activated lymphocytes. The myeloid population was constituted by promyelocytes, myelocytes and metamyelocytes. Promyelocytes and myelocytes capable of cell division are responsible for the increase of 3H-thymidine incorporation observed in transplanted patient PBL. In conclusion our data suggest that in allograft recipients the immunosuppressive therapy with GC and azathioprine may inhibit the lymphocyte blast transformation and can influence the release of immature myeloid cells responsible for the PBL increased 3H-thymidine incorporation.

Antibodies, Monoclonal↗
PubMed1984

Ia- and IgG-Fc receptor-positive accessory cell sustains peripheral T lymphocyte but not thymocyte mitogenesis induced by OKT3 monoclonal antibody.

The proliferative responses of human peripheral blood mononuclear cells (PBL) and thymocytes to OKT3 monoclonal antibody have been investigated. The PBL response to OKT3 was maximal after 72 hr while that of thymocytes was inappreciable at all times measured. Unlike phytohemagglutinin, OKT3 was unable to elicit the mitogenesis of adherent cell-depleted T cells in spite of the presence of exogenously added Interleukin 1 and/or Interleukin 2. The addition of autologous or heterologous adherent cells restored the OKT3 mitogenic response of peripheral purified T cells but not of thymocyte cultures. The adherent cell population that was able to sustain the OKT3-elicited T-cell mitogenesis was constituted by Ia-, Fc receptor-positive cells. These data suggest that the adherent cell-T cell interaction is mediated via the Fc portion of the OKT3 molecule. Furthermore, unlike peripheral T cells, T3-positive thymocytes, which represent the more mature. PHA-responsive subset within the thymus, are unable to cooperate with accessory cells when pulsed with OKT3 monoclonal antibody.

Antibodies, Monoclonal↗